TEVA PHARMACEUTICAL INDUSTRIES LTD

Pharmaceutical Preparations·TEL AVIV·FY end 12/31·CIK 818686

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Richard FrancisPresident and Chief Executive Officer	$1.7M	$12.0M	—	$4.8M	$641.3K	$19.2M
Evan LippmanExecutive Vice President, Business Development	$496.9K	$4.9M	—	$1.8M	$50.3K	$7.2M
Eli KalifExecutive Vice President, Chief Financial Officer	$1.0M	$3.8M	—	$1.8M	$360.7K	$7.0M
Dr. Eric HughesExecutive Vice President, Global R&D and Chief Medical Officer	$829.2K	$3.7M	—	$1.6M	$149.9K	$6.3M
Christine FoxExecutive Vice President, US Commercial	$849.2K	$3.4M	—	$1.6M	$38.3K	$5.9M

Richard Francis · FY 2025

Stock awards$12.0M63%

Performance bonus$4.8M25%

Salary$1.7M9%

Other$641.3K3%

TSR % vs. CEO comp actually paid · 6 fiscal years · Item 402(v) disclosure

TSR

CEO comp

FY20

-2%

$4M

FY21

-17%

$8M

FY22

-5%

$17M

FY23

+8%

$26M

FY24

+128%

$41M

FY25

+223%

$55M

CEO total compMedian employeePay ratio (right axis)